Regular paper
Hyaline membrane disease in black newborns: does fetal lung maturation occur earlier?

https://doi.org/10.1016/0028-2243(94)90031-0Get rights and content

Abstract

Debate has developed among several authors about possible accelerated maturation of black fetuses in comparison with whites. In Guadeloupe, French West Indies, where 85% of the population is of black African-American origin, it has been noted that the incidence of hyaline membrane disease (HMD) represents a significant drop beginning after the 32nd week of gestation. Over a 3-year period, 419 black low-birthweight singleton newborns were admitted in the University Hospital's Neonatal Department covering 70% of all births of the island. The incidence of HMD was 50% among very low birthweight (< 1500 g) and 8.3% among moderate low birthweight (≥ 1500 g; P < 0.001). The incidence of HMD was 48.8% among the very preterm (< 32 weeks) and 7.8% (26331) among the moderate preterm (≥32 weeks; P < 0.001). These differences were similar for appropriate for gestational age and small for gestational age infants. Significant differences remained after controlling for several maternal risk factors. These results suggest that the 32nd week of gestation represents a significant drop in the risk for respiratory distress syndrome in black premature compared with that reported in literature on European infants (34th week) and therefore may implicate different obstetrical decisions in the management of critical pregnancies in this population.

References (27)

  • LO Lubchenko

    Assessment of gestational age and development at birth

    Pediatr Clin North Am

    (1970)
  • O Hjalmarson

    Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study

    Acta Paediatr Scand

    (1981)
  • PM Farrel et al.

    Epidemiology of hyaline membrane disease in the United States: analysis of national mortality statistics

    Pediatrics

    (1976)
  • Cited by (22)

    • Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia

      2019, Journal of Pediatrics
      Citation Excerpt :

      There was no difference in survival between black and white infants even after adjusting for GA (Table I), suggesting that differences in mortality rates could not account for the difference in BPD prevalence between black and white infants. Previous studies have suggested that black infants have more “mature” lungs at birth,11,23-26 higher scores on Ballard examination,27 lower birth weight,28 and shorter natural duration of pregnancy.29,30 We examined the rate of early surfactant use by race as a surrogate marker for lung maturity/RDS.

    • Race Effects of Inhaled Nitric Oxide in Preterm Infants: An Individual Participant Data Meta-Analysis

      2018, Journal of Pediatrics
      Citation Excerpt :

      One trial (Schreiber 2003)10 was a single-center study, but the other two (NOCLD, NEWNO)11,16 were multicenter trials involving a total of 54 different sites. Despite the similarity between racial groups in gestational age (Table III), it is possible that African American infants were more developmentally mature, as has been proposed based on population data for gestational age at delivery,32 and that maturity impacts responsiveness to iNO. However, this was not observed in our analysis by gestational age (data not presented).

    • Race, prematurity and immaturity

      2007, Early Human Development
    • Defects in Surfactant Synthesis: Clinical Implications

      2006, Pediatric Clinics of North America
      Citation Excerpt :

      The report by Avery and Mead established that developmentally regulated surfactant deficiency attributable to reduction in the dominant surfactant phospholipid, phosphatidylcholine, causes neonatal respiratory distress syndrome in premature infants [14–17]. Studies of different ethnic groups, gender, targeted gene ablation in murine lineages, and recent clinical reports of monogenic causes of neonatal respiratory distress syndrome have suggested strongly that genetic mechanisms contribute significantly to risk for respiratory distress syndrome in newborn infants [18–46]. In addition, despite improvement in neonatal survival attributable to surfactant replacement therapy, long-term respiratory morbidity has persisted [4,47–52].

    View all citing articles on Scopus
    View full text